SHANGHAI,, Jan. 24, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics" or "the Company"), (Nasdaq: CHBT) the leading developer, manufacturer and distributor of probiotics products in China, today announced preliminary, unaudited revenues for fiscal year 2011 third quarter ended December 31, 2010.
Preliminary unaudited fiscal year 2011 third quarter revenues were between $32 million and $33 million compared with $23 million for the same period in fiscal year 2010. The strong top line growth was mainly due to the ongoing demand of the company's retail nutritional supplement products and growing acceptance of its bulk additive and cultures probiotics products by Chinese animal feed and dairy producers. Encouraged by the government, both the academia and corporations have been increasing their efforts in expanding the application of probiotics as well as its potential as a replacement for anti-biotics in China. China-Biotics continues to invest in R&D and has increased exchanges with multinational probiotics producers. The company has scheduled to report its fiscal year 2011 third quarter results on Feb 9, 2011.
As of December 31, 2010, total bulk customers were 51, including 22 additives customers in animal feed, functional food and pharmaceuticals, as well as 29 customers in dairy cultures. Bulk additive and cultures products are sold under the brand name "Biogrowing" (English) or "Runying" (Chinese pronunciation). In addition, there were a total of 34 retail distributors, including the 4 recently contracted distributors in the Pan-Beijing area and online shopping platform Rokuten, selling the Company's retail products in malls, supermarkets, functional food stores and online. In light of double digit rise in labor costs and leases in operating retail outlets in metropolitan areas in China, the company has successfully shifted its retail product
|SOURCE China-Biotics, Inc.|
Copyright©2010 PR Newswire.
All rights reserved